CXCR1 and infective vaginitis: Cc-elafin provided 56% protection (P = 0.0036) from vaginal infection with HIV-1, with five of nine mice remaining HIV-1 negative, as determined by a lack of detection of p24 or viral RNA (Fig. 4c and 5c).